PH22531A - Stable composition of interferon - Google Patents

Stable composition of interferon

Info

Publication number
PH22531A
PH22531A PH31752A PH31752A PH22531A PH 22531 A PH22531 A PH 22531A PH 31752 A PH31752 A PH 31752A PH 31752 A PH31752 A PH 31752A PH 22531 A PH22531 A PH 22531A
Authority
PH
Philippines
Prior art keywords
interferon
stable composition
stable
composition
Prior art date
Application number
PH31752A
Other languages
English (en)
Inventor
Yasaburo Akagi
Tetsuo Hoshino
Yasumoto Miuta
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP59010857A external-priority patent/JPS60155136A/ja
Priority claimed from JP60002585A external-priority patent/JPS61161222A/ja
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of PH22531A publication Critical patent/PH22531A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/57—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/811—Interferon
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/14—Lymphokine; related peptides
    • Y10S930/142—Interferon

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
PH31752A 1984-01-23 1985-01-22 Stable composition of interferon PH22531A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP59010857A JPS60155136A (ja) 1984-01-23 1984-01-23 γ型インタ−フエロン組成物
JP60002585A JPS61161222A (ja) 1985-01-09 1985-01-09 γ型インタ−フエロンフラグメントの組成物

Publications (1)

Publication Number Publication Date
PH22531A true PH22531A (en) 1988-10-17

Family

ID=26336000

Family Applications (1)

Application Number Title Priority Date Filing Date
PH31752A PH22531A (en) 1984-01-23 1985-01-22 Stable composition of interferon

Country Status (9)

Country Link
US (1) US4714611A (fr)
EP (1) EP0150067A3 (fr)
KR (1) KR850005455A (fr)
AU (1) AU569365B2 (fr)
DK (1) DK28985A (fr)
GR (1) GR850158B (fr)
NZ (1) NZ210897A (fr)
PH (1) PH22531A (fr)
PT (1) PT79854B (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5702699A (en) * 1982-09-23 1997-12-30 Cetus Corporation Process for the recovery of lipophilic proteins
US5643566A (en) * 1982-09-23 1997-07-01 Cetus Corporation Formulation processes for lipophilic proteins
IL75302A0 (en) * 1984-06-06 1985-09-29 Takeda Chemical Industries Ltd Novel polypeptide and production thereof
EP0168008A3 (fr) * 1984-07-10 1986-12-30 Takeda Chemical Industries, Ltd. Composition stable d'interféron-gamma
US4933433A (en) * 1986-01-31 1990-06-12 E. I. Du Pont De Nemours And Company Recombinant interleukin-2 composition and process for making it
DE3621828A1 (de) * 1986-06-28 1988-01-14 Biotest Pharma Gmbh Stabilisierung eines fuer therapeutische zwecke, insbesondere beim menschen, bestimmten interleukin-2-praeparates sowie dieses praeparat enthaltende stabilisierte waessrige loesung oder feststoff
US5183746A (en) * 1986-10-27 1993-02-02 Schering Aktiengesellschaft Formulation processes for pharmaceutical compositions of recombinant β-
CA1294215C (fr) * 1986-10-27 1992-01-14 Ze'ev Shaked Compositions pharmaceutiques d'interferon beta recombinant et methodes de formulation
US4895716A (en) * 1987-06-09 1990-01-23 Biogen, Inc. Stabilized formulations of gamma interferons
CA1327161C (fr) * 1987-09-01 1994-02-22 Mitsugu Kobayashi Composition pharmaceutique lyophilisee d'un derive de neocarzinostatine
US5151265A (en) * 1987-11-03 1992-09-29 Genentech, Inc. Gamma interferon formulation
US5078997A (en) * 1988-07-13 1992-01-07 Cetus Corporation Pharmaceutical composition for interleukin-2 containing physiologically compatible stabilizers
DE3900649A1 (de) * 1989-01-11 1990-07-12 Boehringer Mannheim Gmbh Verfahren zur abloesung eines analyten von seinem bindeprotein
LT3987B (en) 1992-02-17 1996-06-25 Fermentas Biotech Inst Stabilized interferon compositions
CN1175901C (zh) * 1999-12-06 2004-11-17 天津华立达生物工程有限公司 一种稳定的干扰素水溶液
US7780967B2 (en) 2000-02-08 2010-08-24 Allergan, Inc. Reduced toxicity Clostridial toxin pharmaceutical compositions
CN1258379C (zh) * 2000-02-08 2006-06-07 阿勒根公司 肉毒杆菌毒素药物组合物
US20030118598A1 (en) * 2000-02-08 2003-06-26 Allergan, Inc. Clostridial toxin pharmaceutical compositions
US20060269575A1 (en) * 2000-02-08 2006-11-30 Allergan, Inc. Botulinum toxin pharmaceutical compositions formulated with recombinant albumin
US8632785B2 (en) 2000-02-08 2014-01-21 Allergan, Inc. Clostridial toxin pharmaceutical composition containing a gelatin fragment
DE10204792A1 (de) * 2002-02-06 2003-08-14 Merck Patent Gmbh Lyophilisierte Zubereitung enthaltend Immuncytokine
US6982080B2 (en) * 2002-03-15 2006-01-03 Wyeth Hydroxyethyl starch—containing polypeptide compositions
PT2029740E (pt) 2006-05-31 2012-07-06 Genzyme Corp Utilização de polissacáridos para promoção de actividade enzimática
JP2011520889A (ja) * 2008-05-15 2011-07-21 バクスター・インターナショナル・インコーポレイテッド 安定な医薬製剤
FI126979B (en) 2016-02-29 2017-09-15 Faron Pharmaceuticals Oy Lyophilized pharmaceutical formulation and use thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2244543B1 (fr) * 1973-07-27 1977-07-01 Inst Nl Sante Rech Medica
US4100150A (en) * 1975-11-04 1978-07-11 G. D. Searle & Co. Stabilization of interferon against mechanical stress using thioctic acid
JPS5651995A (en) * 1979-10-05 1981-05-09 Green Cross Corp:The Preparation of interferon
JPS5821691A (ja) * 1981-07-29 1983-02-08 Mochida Pharmaceut Co Ltd α−及びβ−インタ−フェロンの精製方法
EP0080879B1 (fr) * 1981-11-28 1986-10-01 Sunstar Kabushiki Kaisha Composition pharmaceutique contenant de l'interféron stabilisé
EP0123291A2 (fr) * 1983-04-20 1984-10-31 Kyowa Hakko Kogyo Co., Ltd. Méthode de stabilisation d'interféron
EP0168008A3 (fr) * 1984-07-10 1986-12-30 Takeda Chemical Industries, Ltd. Composition stable d'interféron-gamma

Also Published As

Publication number Publication date
PT79854B (en) 1986-12-15
AU569365B2 (en) 1988-01-28
US4714611A (en) 1987-12-22
AU3801685A (en) 1985-08-01
NZ210897A (en) 1988-04-29
DK28985D0 (da) 1985-01-22
EP0150067A3 (fr) 1986-12-30
DK28985A (da) 1985-07-24
EP0150067A2 (fr) 1985-07-31
PT79854A (en) 1985-02-01
KR850005455A (ko) 1985-08-26
GR850158B (fr) 1985-05-21

Similar Documents

Publication Publication Date Title
PT80247A (en) Stable composition of interleukin-2
PH22531A (en) Stable composition of interferon
IL75533A (en) Preparation of heteroaryloxyacetamides
DE3560396D1 (en) Novel interferon alphas
NZ215563A (en) Interferon composition
GB8420543D0 (en) Compositions of matter
GB8507789D0 (en) Preparation of 2-amino-s-triazines
ZA852302B (en) Stable composition of interleukin-2
GB8407547D0 (en) Composition of polymers
GB8521455D0 (en) Stable compositions of anthralin
IL76249A (en) Preparation of fluoroformates
IL74093A0 (en) Stable composition of gamma-interferon
ZA85497B (en) Stable composition of ypsilon-interferon
DE3566540D1 (en) Preparation of fluoropyridines
GB8429545D0 (en) Compositions of matter
GB8520403D0 (en) Preparation of aminolactone
GB8422162D0 (en) Preparation of alkyfurans
IL76216A0 (en) Preparation of sulphonylisoureas and-thioureas
EP0179479A3 (en) Ceramic composition
GB8422918D0 (en) Compositions of matter
GB8422916D0 (en) Compositions of matter
GB8407861D0 (en) Manufacture of components
EP0177964A3 (en) Ceramic composition
IL77340A (en) Manufacture of oxetanones
GB8430824D0 (en) Set of cutlery